Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Semaglutide and colorectal tumors: methodological pitfalls and translational gaps - [PMID: 41202322] Laboratory literature summary: Semaglutide and colorectal tumors: methodological pitfalls and translational gaps Letter to the Editor
In the field of oncology, GLP-1RAs have predominantly demonstrated anticancer effects, although a limited number of studies suggest potential tumor-promoting properties (13,75)
Nguyen KT, Mun SH, Yang J, et al
10.1053/j.gastro.2024.04.029 82 WeiS.WangL.EvansP
Potential heart benefits A study originally published in the J ournal of Experimental and Therapeutic Medicine found that some GLP-1 medications may lower the risk of heart disease
US$ 26.64
US$ 21.58
US$ 27.94
US$ 26.71
US$ 21.28
US$ 21.85
US$ 21.97
US$ 23.46
US$ 29.64
US$ 29.96
US$ 22.21
US$ 28.02
